Race Disparities in Proton Radiotherapy Use for Cancer Treatment in Patients Enrolled in Children's Oncology Group Trials

Affiliations

¹ Dana-Farber Cancer Institute, Department of Radiation Oncology, Brigham and Women's Hospital, Boston, Massachusetts.
² Division of Population Sciences, Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
³ Imaging and Radiation Oncology Core (IROC RI), Lincoln, Rhode Island.
⁴ Department of Radiation Oncology, University of Minnesota Medical School, Minneapolis.

Danielle S Bitterman et al. JAMA Oncol. 2020.

. 2020 Sep 1;6(9):1465-1468.

doi: 10.1001/jamaoncol.2020.2259.

¹ Dana-Farber Cancer Institute, Department of Radiation Oncology, Brigham and Women's Hospital, Boston, Massachusetts.
² Division of Population Sciences, Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
³ Imaging and Radiation Oncology Core (IROC RI), Lincoln, Rhode Island.
⁴ Department of Radiation Oncology, University of Minnesota Medical School, Minneapolis.

Abstract

This quality improvement study examines disparities in proton radiotherapy use in patients enrolled in Children’s Oncology Group Trials

1. Yock TI, Bhat S, Szymonifka J, et al. . Quality of life outcomes in proton and photon treated pediatric brain tumor survivors. Radiother Oncol. 2014;113(1):89-94. doi:10.1016/j.radonc.2014.08.017 - DOI - PMC - PubMed
1. Ladra MM, Szymonifka JD, Mahajan A, et al. . Preliminary results of a phase II trial of proton radiotherapy for pediatric rhabdomyosarcoma. J Clin Oncol. 2014;32(33):3762-3770. doi:10.1200/JCO.2014.56.1548 - DOI - PMC - PubMed
1. Kahalley LS, Peterson R, Ris MD, et al. . Superior intellectual outcomes after proton radiotherapy compared with photon radiotherapy for pediatric medulloblastoma. J Clin Oncol. 2019:Jco1901706. - PMC - PubMed
1. American Community Survey (ACS) 2015; https://www.census.gov/programs-surveys/acs. Accessed December 27, 2019.
1. Odei B, Frandsen JE, Boothe D, Ermoian RP, Poppe MM. Patterns of care in proton radiation therapy for pediatric central nervous system malignancies. Int J Radiat Oncol Biol Phys. 2017;97(1):60-63. doi:10.1016/j.ijrobp.2016.09.011 - DOI - PubMed